FIGURE

Fig. 3.

ID

ZDB-FIG-200910-15

Publication

Spinazzola et al., 2020 - Effect of serotonin modulation on dystrophin-deficient zebrafish

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3.

Short-term assay of SSRIs. (A–F) Treatment with citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine and sertraline did not significantly decrease the percentage of zebrafish exhibiting the affected muscle phenotype detected by birefringence. Treatment with 2.5 μg/ml aminophylline significantly decreased the percentage of affected fish. (G) Zebrafish treated with fluoxetine exhibited dose-dependent toxicity. Data represent means±s.e.m.; *P<0.05 versus paired control by one-way ANOVA and Bonferroni post-hoc test. Values above each column indicate the number of sapje (N) and sapje-like (n) fish treated with the respective drug.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biol. Open